Paragon 28 Acquires Disior

Paragon 28 Acquires Assets of Additive Orthopaedics

June 1, 2021

Medical Devices

Paragon 28, Inc. acquired the product lines and related assets of Additive Orthopaedics, including the FDA‑cleared 3D‑printed patient‑specific talus spacer and an integrated cloud‑based pre‑operative surgical planning application. The acquisition expands Paragon 28’s foot‑and‑ankle product offering and accelerates its strategy to integrate smart tools, AI and advanced technologies to improve patient outcomes.

Getinge Acquires Paragonix Technologies

August 22, 2024

Medical Devices

Getinge has completed the acquisition of Paragonix Technologies, a U.S. developer of organ preservation devices and transplant logistics services, for an estimated total consideration of USD 477 million (including earn-outs). The deal will make Paragonix a wholly owned subsidiary of Getinge and is intended to expand Getinge's transplant product portfolio and bring Paragonix's technologies to new global markets.

Aptean Acquires Paragon Software Systems

March 5, 2020

Software

Aptean, a global provider of industry-specific enterprise software, has acquired UK-based Paragon Software Systems, a specialist in transportation management, routing and scheduling solutions. The deal expands Aptean’s logistics and route-optimization capabilities and furthers its presence in the European market, adding Paragon’s installed base and customers in food & beverage, retail, distribution and pharmaceutical sectors.

Avanos Medical Acquires Diros Technology Inc.

June 19, 2023

Medical Devices

Avanos Medical, a medical device company headquartered in Alpharetta, Georgia, has entered into a definitive agreement to acquire Diros Technology Inc., a Toronto-based maker of radiofrequency (RF) products for chronic pain management. The purchase expands Avanos' RF product portfolio—adding Diros' Trident technology—to complement its COOLIEF cooled radiofrequency offering and strengthen its position in non-opioid, minimally invasive pain treatments.

Elevance Health Acquires Paragon Healthcare

March 11, 2024

Healthcare Services

Elevance Health has closed its acquisition of Plano, Texas–based Paragon Healthcare, an infusion services and drug therapy provider operating more than 40 ambulatory infusion centers and serving over 35,000 patients. Paragon will operate under Elevance’s CarelonRx pharmacy services segment to expand access to specialty medications and scale infusion capabilities; financial terms were not disclosed (Axios reported the purchase may exceed $1 billion).

Paragon Group Acquires DG3 Europe Business

December 1, 2021

Marketing & Advertising

Paragon Group has acquired the European business of DG3 from Resilience Capital Partners' portfolio company DG3. The deal transfers DG3's UK/European operations to Paragon Customer Communications, enabling DG3 to focus on growth and transformation of its US business while Paragon expands its customer communications capabilities across Europe.